|
Total compounds
|
3678
| |
4228
| |
|
Compounds that are FDA drugs
|
632
| |
676
| |
|
Compounds that are FDA drugs for target disease
|
20
| |
11
| |
|
Compounds that are in clinical trial for target disease
|
154
| |
106
| |
| |
UCDB
|
DCUB
|
UCDB
|
DCUB
|
|
Compounds with FDR < 0.05
|
2435
|
1875
|
2500
|
1668
|
|
Compounds that are clinical drugs with FDR < 0.05 (p-value)
|
131 (6.2E-8)
|
109 (2.7E-7)
|
82 (4.9E-5)
|
67 (4.8E-7)
|
|
FDA drugs with FDR < 0.05
|
427
|
325
|
456
|
317
|
|
FDA drugs with FDR < 0.05 in both UCDB and DCUB
|
244
| |
291
| |
|
FDA drugs for target disease with FDR < 0.05 (p-value)
|
20 (2.5E-4)
|
19 (2.7E-5)
|
10 (2.6E-2)
|
9 (5.3E-3)
|
|
AUC (p-value)
|
0.86 (<1.0E-6)
|
0.81 (<1.0E-6)
|
0.77 (9E-3)
|
0.83 (4.7E-5)
|
|
Number of MAG/DRG
|
237/700
|
75/100
|
333/100
|
46/100
|
